Just imagine Leronlimab ‘s side effect is an improved liver for our HIV patients population that almost have 65% NAFLD… which is twice the average population.

Take that Gilead!

Who will not want to change over to Leronlimab when the secondary issue is also prevented? The miracle molecule is going to take over HIV world wide! That’s what I am seeing…

Anybody see it any different?